Yaz Acne - Treatment for Prevention of Pregnancy, Premenstrual Dysphoric Disorder
Yaz is a low-dose, monophasic oral contraceptive with a 24-day active hormone pill regimen indicated for prevention of pregnancy and the treatment of emotional and physical symptoms of premenstrual dysphoric disorder.Posted: October 2006
Related articles
- FDA Approves New Indication for Yaz to Treat Acne - January 30, 2007
- Yaz Berlex, Inc. - Treatment for Prevention of Pregnancy - March 17, 2006
- FDA Clarifies Status of Yaz PMDD Application - January 25, 2006
- FDA Extends Review Period of New Drug Application for Oral Contraceptive Yaz to First Quarter 2006 - December 9, 2005
- Berlex Receives Approvable Letter From FDA on the Company's Second Oral Contraceptive Containing Drospirenone - November 18, 2004
Yaz (drospirenone and ethinyl estradiol) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
